We estimate that the CEO of CVS HEALTH Corp ($CVS), J. David Joyner, received a compensation of $21,214,084 in 2025. This is an increase of 16.05% from an estimated $17,808,792 in 2024.
These estimates are based on a new DEF14A filing, filed with the SEC on April 03, 2026. Note that parsing errors may occur.
You can track $CVS on Quiver Quantitative's $CVS stock dashboard.
$CVS Stock Government Contracts
We have seen $7,069,230 of award payments to $CVS over the last year.
Here are some of the awards which we have have seen pay out the most over the last year:
- CENTER FOR BIOLOGICS EVALUATION AND RESEARCH (CBER) REQUIREMENT FOR BIOLOGICS EFFECTIVENESS AND SAFETY (BES...: $5,476,406
- CENTER FOR BIOLOGICS EVALUATION AND RESEARCH (CBER) REQUIREMENT FOR BIOLOGICS EFFECTIVENESS AND SAFETY (BES...: $1,381,573
- PHARMACY REPACKAGING: $200,000
- CVS GIFT CARDS: $11,250
To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.
$CVS Stock Congressional Stock Trading
Members of Congress have traded $CVS stock 5 times in the past 6 months. Of those trades, 2 have been purchases and 3 have been sales.
Here’s a breakdown of recent trading of $CVS stock by members of Congress over the last 6 months:
- SENATOR JOHN BOOZMAN purchased up to $15,000 on 01/29.
- REPRESENTATIVE DWIGHT EVANS sold up to $15,000 on 11/21.
- REPRESENTATIVE LISA C. MCCLAIN has traded it 3 times. They made 1 purchase worth up to $15,000 on 10/30 and 2 sales worth up to $30,000 on 10/31, 10/30.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
$CVS Stock Hedge Fund Activity
We have seen 849 institutional investors add shares of $CVS Stock stock to their portfolio, and 837 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 23,387,155 shares (-73.8%) from their portfolio in Q4 2025, for an estimated $1,856,004,620
- WELLINGTON MANAGEMENT GROUP LLP added 12,233,675 shares (+193.2%) to their portfolio in Q4 2025, for an estimated $970,864,448
- DODGE & COX removed 10,666,598 shares (-14.6%) from their portfolio in Q4 2025, for an estimated $846,501,217
- DZ BANK AG DEUTSCHE ZENTRAL GENOSSENSCHAFTS BANK, FRANKFURT AM MAIN added 8,355,230 shares (+822.1%) to their portfolio in Q4 2025, for an estimated $663,071,052
- JPMORGAN CHASE & CO removed 4,072,568 shares (-11.5%) from their portfolio in Q4 2025, for an estimated $323,198,996
- MARSHALL WACE, LLP removed 3,649,256 shares (-99.6%) from their portfolio in Q4 2025, for an estimated $289,604,956
- FRANKLIN RESOURCES INC removed 3,438,834 shares (-47.8%) from their portfolio in Q4 2025, for an estimated $272,905,866
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$CVS Stock Analyst Ratings
Wall Street analysts have issued reports on $CVS in the last several months. We have seen 12 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- UBS issued a "Buy" rating on 12/10/2025
- Barclays issued a "Overweight" rating on 12/10/2025
- Mizuho issued a "Outperform" rating on 12/10/2025
- Truist Securities issued a "Buy" rating on 12/10/2025
- Piper Sandler issued a "Overweight" rating on 12/10/2025
- Wells Fargo issued a "Overweight" rating on 11/13/2025
- TD Cowen issued a "Buy" rating on 11/03/2025
To track analyst ratings and price targets for $CVS Stock, check out Quiver Quantitative's $CVS forecast page.
$CVS Stock Price Targets
Multiple analysts have issued price targets for $CVS recently. We have seen 17 analysts offer price targets for $CVS in the last 6 months, with a median target of $95.0.
Here are some recent targets:
- Jessica Tassan from Piper Sandler set a target price of $99.0 on 03/31/2026
- Lance Wilkes from Bernstein set a target price of $94.0 on 03/12/2026
- Steve Silver from Argus Research set a target price of $90.0 on 01/28/2026
- Michael Cherny from B of A Securities set a target price of $95.0 on 01/27/2026
- Lisa Gill from JP Morgan set a target price of $101.0 on 12/17/2025
- Andrew Mok from Barclays set a target price of $93.0 on 12/10/2025
- David Macdonald from Truist Securities set a target price of $98.0 on 12/10/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
